课题基金 / 基金详情

The Central Virginia Center on Drug Abuse Research

The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
批准号:
10604263
负责人:
William L. Dewey
金额:
$138.02万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-12-01 至 2025-03-31
关键词:
AnimalsAreaAtmosphereBasic ScienceBehaviorBibliographyBiomedical ResearchBody FluidsBrainBreedingCardiovascular systemChemicalsClinical ResearchCollaborationsCore FacilityCore GrantCountryCreativenessDiseaseDrug AddictionDrug abuseEndocannabinoidsEnvironmentEquipmentFacultyFinancial HardshipForensic MedicineFosteringFundingFunding OpportunitiesGastrointestinal tract structureGene ExpressionGenotypeGoalsGrantHumanInfrastructureInstitutionIon ChannelJournalsKnowledgeLaboratoriesLeadershipLettersLipidsMeasurementMeasuresMethodologyModernizationMusMutant Strains MiceNational Heart, Lung, and Blood InstituteNational Institute of Drug AbuseNational Institute of General Medical SciencesNational Institute of Neurological Disorders and StrokeNeuropharmacologyOpioidPaperPerformancePharmaceutical PreparationsPharmacology and ToxicologyPharmacy SchoolsPharmacy facilityPilot ProjectsProductivityPublicationsPublishingRecording of previous eventsRecordsResearchResearch PersonnelResourcesRunningSamplingScientistSignal TransductionSocietiesSubstance AddictionSubstance abuse problemTechnologyTissuesToxicologyTrainingTransgenic OrganismsUnited StatesUnited States National Institutes of HealthUniversitiesUpdateViral VectorVirginiaWorkbasebiological systemscravingdrug of abuseexperiencegastrointestinalgastrointestinal functiongastrointestinal systemimaging facilitiesimprovedinnovationinstrumentinterestliquid chromatography mass spectrometrymedical schoolsneurobehavioralnovelopioid epidemicpreventprogramsreceptorrecruitsuccesstool

项目摘要

项目成果

William L. Dewey的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary – Overall One of the overall goals of this center is to provide an environment in which investigators can conduct new, significant and innovative basic and clinical research utilizing bioanalytical technology, genetically altered mice, neurobehavioral measures and gastrointestinal studies to advance our knowledge of the effects of abused drugs on biological systems. Coordination through the Administrative Core will provide the necessary scientific, financial, and administrative infrastructure to support such an environment. Further, this center will provide these areas of expertise to enhance the research of the 21 projects in VCU's Department of Pharmacology and Toxicology currently funded by NIDA and 13 funded through other NIH institutes (NIAAA: 2; NINDS: 2; NIGMS: 1; NCI: 1; NIDDKD: 4; NHLBI: 2) or other federal agencies (NSF: 1). These cores will provide current and innovative expertise that is improved over the methodologies used in previously funded research. This will enhance previously funded research and foster new collaborative research in ways that could not have been contemplated just a few years ago. A Bioanalytical Core, Mutant Mouse/Viral Vector Core, Neuropharmacology Core, and a Gastrointestinal Function Core will provide the opportunity for funded researchers to broaden the scope of their work to transform knowledge in various creative ways. The ability to continue to provide genetically altered mice with appropriate genotyping, etc., and expertise in viral vector technology are major assets of this Center. Being able to have a collaborator elucidate receptor functional changes as part of the neuropharmacology core, identify a substance found to alter behavior or craving in the bioanalytical core, or identify deleterious effects in the gastrointestinal tract provides the atmosphere for new and creative mechanistic research. This type of collaboration among scientists at different institutions is rare and requires many months or perhaps years to establish, if at all. In this center this type of collaboration will be the norm. We are committed to providing considerable institutional support, such as the use of a modern imaging center and a forensic toxicology laboratory established by the university. We have commitments from the Dean of the School of Medicine, the Dean of the School of Pharmacy, and the Vice President for Research and Innovation to provide matching funds for our Pilot Projects program. The cores will also be available for use by NIDA-funded investigators at the University of Virginia and Eastern Virginia Medical School. Scholars at the relatively new Pharmacy School at Hampton University have begun collaborations with our researchers, as they continue to develop and expand their research programs. We will also continue to share all aspects of this center with scientists throughout the country. We have included numerous letters of support from collaborating investigators at other institutions within Virginia and across the country, showcasing the strength of our Center and its importance to drug abuse research being conducted throughout the United States.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Examination of the behavioral effects of ketamine in Sprague-Dawley and Wistar Kyoto rats.
检查氯胺酮对 Sprague-Dawley 和 Wistar京都大鼠的行为影响。
DOI: --
发表时间: 2022
期刊: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子: --
作者: [Zhang,Fan, Baasansukh,Tegshjargal, Shelton,KeithL, Porter,JosephH, Nicholson,KatherineL]
通讯作者: Nicholson,KatherineL
High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
采用高效液相色谱串联质谱法测定尿液样本中的 9 种致幻性 25-NBOMe 设计药物。
DOI: 10.1093/jat/bku005
发表时间: 2014
期刊: Journal of analytical toxicology
影响因子: 2.5
作者: [Poklis,JustinL, Clay,DeborahJ, Poklis,Alphonse]
通讯作者: Poklis,Alphonse
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies.
四氢大麻酚和大麻二酚在制备的质量控制食用布朗尼中的稳定性。
DOI: 10.1093/jat/bkw114
发表时间: 2017
期刊: Journal of analytical toxicology
影响因子: 2.5
作者: [Wolf,CarlE, Poklis,JustinL, Poklis,Alphonse]
通讯作者: Poklis,Alphonse
DOI: 10.1037/pha0000391
发表时间: 2021-08
期刊: Experimental and clinical psychopharmacology
影响因子: 2.3
作者: [Peters EN, Herrmann ES, Smith C, Wilhelm JA, Koszowski B, Halquist M, Kosmider L, Poklis J, Roth S, Bart S, Pickworth WB]
通讯作者: Pickworth WB
21
    Training in the pharmacology of abused drugs
    • 批准号:
      9386216
    • 项目类别:
    • 资助金额:
      $0.0万
    • 财政年份:
      2016
    • 负责人:
      William L. Dewey
    • 依托单位:
    The Central Virginia Center on Drug Abuse Research
    • 批准号:
      9189703
    • 项目类别:
    • 资助金额:
      $59.74万
    • 财政年份:
      2013
    • 负责人:
      William L. Dewey
    • 依托单位:
    The Central Virginia Center on Drug Abuse Research
    • 批准号:
      10374821
    • 项目类别:
    • 资助金额:
      $138.02万
    • 财政年份:
      2013
    • 负责人:
      William L. Dewey
    • 依托单位:
    The Central Virginia Center on Drug Abuse Research
    • 批准号:
      8552155
    • 项目类别:
    • 资助金额:
      $65.18万
    • 财政年份:
      2013
    • 负责人:
      William L. Dewey
    • 依托单位:
    国内基金
    海外基金
    层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
    • 批准号:
      2021JJ40433
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
      孙磊
    • 依托单位:
    寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
    • 批准号:
      32001603
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      段真珍
    • 依托单位:
    AREA国际经济模型的移植.改进和应用
    • 批准号:
      18870435
    • 项目类别:
      面上项目
    • 资助金额:
      2.0万元
    • 批准年份:
      1988
    • 负责人:
      史树中
    • 依托单位: